Online first
Clinical vignette
Published online: 2025-04-28
Hereditary hemorrhagic telangiectasia and atrial fibrillation — percutaneous left atrial appendage closure as an alternative strategy for anticoagulation
Abstract
Not available
References
- Virk ZM, Zhang E, Rodriguez-Lopez J, et al. Safety, tolerability, and effectivness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic teleangiectasia. J Thromb Haemost. 2023; 21(1): 26–36.
- Potpara T, Grygier M, Häusler KG, et al. Practical guide on left atrial appendage closure for the non-implanting physician: An international consensus paper. Europace. 2024; 26(4): euae035.
- Chin CJ, Rotenberg BW, Witterick IJ. Epistaxis in hereditary hemorrhagic telangiectasia: An evidence based review of surgical management. J Otolaryngol Head Neck Surg. 2016; 45: 3.
- Gofus J, Zacek P, Shahin Y, et al. Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice. Pol Heart J. 2024; 82(3): 267–275.
- Kowalewski M, Ogorzelec N, Stec S, et al. First-in-Poland thoracoscopic left atrial appendage closure using the Novel AtriClip® PRO-V device in a patient after heart surgery and with an LAA thrombus. Pol Heart J. 2025; 83(2): 221–222.
